Actively Recruiting
Exposure to Hepatitis E Virus in Occitania, France
Led by University Hospital, Toulouse · Updated on 2024-05-16
5000
Participants Needed
1
Research Sites
47 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of the proposed work is to determine the seroprevalence of HEV in 2023 in a population of blood donors living in Occitania. Compare the current frequency of anti-HEV IgG and IgM markers with that of 2011. The serological techniques used and the questionnaires will be similar
CONDITIONS
Official Title
Exposure to Hepatitis E Virus in Occitania, France
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Blood donors aged 18 to 70 years
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Purpan University Hospital
Toulouse, France, 31059
Actively Recruiting
Research Team
J
Jacques Izopet, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here